Weil Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $388K | Sell |
1,784
-462
| -21% | -$102K | 0.09% | 91 |
|
|
2025
Q4 | $513K | Buy |
2,246
+220
| +11% | +$50.1K | 0.12% | 80 |
|
|
2025
Q3 | $469K | Buy |
2,026
+46
| +2% | +$9.37K | 0.11% | 83 |
|
|
2025
Q2 | $367K | Sell |
1,980
-252
| -11% | -$46.8K | 0.1% | 90 |
|
|
2025
Q1 | $468K | Sell |
2,232
-1,831
| -45% | -$356K | 0.14% | 74 |
|
|
2024
Q4 | $722K | Buy |
4,063
+43
| +1% | +$7.91K | 0.25% | 59 |
|
|
2024
Q3 | $794K | Hold |
4,020
| – | – | 0.26% | 72 |
|
|
2024
Q2 | $690K | Hold |
4,020
| – | – | 0.25% | 79 |
|
|
2024
Q1 | $732K | Sell |
4,020
-1,670
| -29% | -$288K | 0.29% | 72 |
|
|
2023
Q4 | $882K | Hold |
5,690
| – | – | 0.39% | 51 |
|
|
2023
Q3 | $848K | Hold |
5,690
| – | – | 0.42% | 51 |
|
|
2023
Q2 | $767K | Hold |
5,690
| – | – | 0.34% | 65 |
|
|
2023
Q1 | $907K | Hold |
5,690
| – | – | 0.41% | 60 |
|
|
2022
Q4 | $920K | Hold |
5,690
| – | – | 0.42% | 56 |
|
|
2022
Q3 | $764K | Hold |
5,690
| – | – | 0.47% | 51 |
|
|
2022
Q2 | $871K | Buy |
5,690
+40
| +0.7% | +$6.11K | 0.49% | 54 |
|
|
2022
Q1 | $916K | Sell |
5,650
-166
| -3% | -$24.1K | 0.46% | 58 |
|
|
2021
Q4 | $787K | Buy |
5,816
+123
| +2% | +$14.5K | 0.37% | 65 |
|
|
2021
Q3 | $614K | Hold |
5,693
| – | – | 0.32% | 68 |
|
|
2021
Q2 | $641K | Sell |
5,693
-167
| -3% | -$18.8K | 0.32% | 76 |
|
|
2021
Q1 | $634K | Hold |
5,860
| – | – | 0.36% | 73 |
|
|
2020
Q4 | $628K | Hold |
5,860
| – | – | 0.38% | 64 |
|
|
2020
Q3 | $513K | Hold |
5,860
| – | – | 0.37% | 67 |
|
|
2020
Q2 | $575K | Sell |
5,860
-3
| -0.1% | -$264 | 0.49% | 50 |
|
|
2020
Q1 | $447K | Sell |
5,863
-300
| -5% | -$25.6K | 0.42% | 51 |
|
|
2019
Q4 | $546K | Sell |
6,163
-210
| -3% | -$17.4K | 0.42% | 51 |
|
|
2019
Q3 | $483K | Sell |
6,373
-2,500
| -28% | -$171K | 0.36% | 53 |
|
|
2019
Q2 | $645K | Buy |
8,873
+60
| +0.7% | +$4.72K | 0.52% | 44 |
|
|
2019
Q1 | $710K | Hold |
8,813
| – | – | 0.59% | 43 |
|
|
2018
Q4 | $812K | Sell |
8,813
-85
| -1% | -$7.47K | 0.74% | 32 |
|
|
2018
Q3 | $842K | Sell |
8,898
-45
| -0.5% | -$4.27K | 0.69% | 37 |
|
|
2018
Q2 | $829K | Buy |
8,943
+135
| +2% | +$13.2K | 0.7% | 37 |
|
|
2018
Q1 | $834K | Buy |
8,808
+2,500
| +40% | +$275K | 0.78% | 36 |
|
|
2017
Q4 | $610K | Buy |
+6,308
| New | +$594K | 0.56% | 42 |
|
Other funds holding ABBV
VCM
VPM
Weil Company's ABBV Position: Q1 2026 in Review
Weil Company reduced its AbbVie (ABBV) stake by 21% in Q1 2026, selling an estimated $102K and leaving 1,784 shares worth $388K. The position accounts for 0.09% of the portfolio, ranked #91.
Weil Company first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $920K in Q4 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Weil Company held 1,784 shares of AbbVie worth $388K as of Q1 2026.
- Weil Company sold 462 AbbVie shares in Q1 2026, an estimated $102K.
- AbbVie made up 0.09% of Weil Company's portfolio in Q1 2026, its #91 holding.
- Weil Company first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- Weil Company's AbbVie position peaked at $920K in Q4 2022.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Weil Company's 13F filing for Q1 2026, filed 15 Apr 2026.